76-82 of 82
New Treatments in IBD – Professional Webinar Series
CME/CENew Treatments in IBD – Professional Webinar Series
Miguel Regueiro, MD
Katie Falloon, MD
Shubha Bhat, PharmD
The NASH Epidemic: Highlights from the AMCP 2023 Symposium
CME/CEThe NASH Epidemic: Highlights from the AMCP 2023 Symposium
Mazen Noureddin, MD, MHSc
In Your Waiting Room: The Virtual IBS-C Patient Clinical Experience
CME/CEIn Your Waiting Room: The Virtual IBS-C Patient Clinical Experience
Darren Brenner, MD
Brooks D. Cash, MD, AGAF, FACG, FACP, FASGE
Virtual IBD Clinic: Updates in Diagnostic, Therapeutic, and Prognostic Strategies
CME/CEVirtual IBD Clinic: Updates in Diagnostic, Therapeutic, and Prognostic Strategies
Sushila R. Dalal, MD
Virtual IBD Clinic: Surgical and Pharmacological Therapeutics
CME/CEVirtual IBD Clinic: Surgical and Pharmacological Therapeutics
Jenny S. Sauk, MD
Unresectable HCC: An Emerging Era of Combination Therapy – A Clinical Convergence®
CME/CEUnresectable HCC: An Emerging Era of Combination Therapy – A Clinical Convergence®
Richard S. Finn, MD
Amit Singal, MD, MS
Mark Yarchoan, MD
- advertisement
Decision Point IBD: Debating the Factors That Influence Patient-Centric Treatment
CME/CEDecision Point IBD: Debating the Factors That Influence Patient-Centric Treatment
Uma Mahadevan, MD
Fernando S. Velayos, MD, MPH
